UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan · Delayed Price · Currency is TWD 62.50
+0.50 (0.81%)
Jul 22, 2025, 1:03 PM CST
UnicoCell Biomed Market Cap
UnicoCell Biomed has a market cap or net worth of 3.79 billion as of July 22, 2025. Its market cap has decreased by -19.47% in one year.
Market Cap
3.79B
Enterprise Value
3.22B
Revenue
39.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
62.50
Market Cap Chart
Since December 25, 2020, UnicoCell Biomed's market cap has increased from 1.73B to 3.79B, an increase of 119.48%. That is a compound annual growth rate of 18.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2025 | 3.79B | -4.94% |
| Dec 31, 2024 | 3.99B | -13.33% |
| Dec 29, 2023 | 4.60B | 239.58% |
| Dec 30, 2022 | 1.36B | -17.13% |
| Dec 30, 2021 | 1.64B | 1.26% |
| Dec 31, 2020 | 1.62B | -6.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 195.43B |
| PharmaEssentia | 181.63B |
| Bora Pharmaceuticals Co., LTD. | 86.16B |
| Lotus Pharmaceutical | 58.37B |
| Oneness Biotech | 31.42B |
| Polaris Group | 30.05B |
| Center Laboratories | 26.32B |
| TaiMed Biologics | 23.62B |